This weeks Items

[an error occurred while processing this directive]

Item #10 

Triple Oral Therapy Effective for Long-term Management of Type 2 Diabetes

Triple oral antidiabetic therapy is an effective long-term treatment for many patients with type 2 diabetes, who initially achieve gylcemic control with triple oral therapy.

Drs. David S. Bell and Fernando Ovalle, from University of Alabama at Birmingham School of Medicine, in Birmingham, Alabama, United States, studied 35 patients with type 2 diabetes, who had been treated with a combination of sulfonylurea, metformin and a thiazolidinedione for 18 to 45 months (mean 37 months).

Twenty-six (74 percent) patients achieved good control of blood glucose levels, with a mean glycated hemoglobin (HbA1c) value of 6.9 percent, the researchers reported. In the nine other patients, treatment failed to control blood glucose levels, and insulin therapy was necessary after a mean of 30 months. Their mean HbA1c value in this group was 8.8 percent.

A search for potential predictors of treatment success or failure revealed that both groups had similar baseline characteristics, including age, duration of diabetes, weight, body mass index, HbA1c values, and stimulated C-peptide levels. None of these factors were found to correlate with response to therapy. Both groups gained similar amounts of weight during the study period (14.2 lb versus 11.6 lb, respectively; p=0.54), the investigators noted.

The only difference they observed was a significant increase in the stimulated C-peptide levels at follow-up in patients who had good glycemic control (p=0.002) compared to a nonsignificant increase in the group that failed to maintain glycemic control (p=0.46).

"Triple oral antidiabetic therapy is an effective long-term treatment for a substantial proportion of patients with type 2 diabetes, who initially achieve glycemic control with triple oral therapy, particularly those in whom production of endogenous insulin is increased when a thiazolidinedione is added," the researchers concluded.
Endocr Pract 2002; 8: 271-275


73% of graduating students have some type of guaranteed student loan. You can refinance those loans at a much lower rate. Click here to get more info

[an error occurred while processing this directive]

 

[an error occurred while processing this directive]

 


Get the FREE Diabetes In Control Newsletter!

  • * Free Diabetes Related Information.
  • * Participation in Current and Future Studies
  • * Participation in Surveys (honorariums)
  • * Information that better helps your patients.
  • * Stay Current with the most updated information on treatments and medical devices.
  • * Learn about new studies......plus much more...

Simply Enter your Email Address Below to begin receiving the FREE Diabetes In Control Weekly Newsletter in your mailbox.
 

Please specify the format you can receive the newsletter in below

HTML Text AOL

Home · About Us · Advertise · Classifieds · Current News · Downloads · Education · Features · Feedback · Links · New Products · Past Newsletters · Recommend Us · Search · Show All Stories · Studies · Subscribe · Test Your Knowledge · Tools For Your Practice · Writers Archives · Search Our Archives · NewsFeed

We subscribe to the HONcode principles of the Health On the Net Foundation

©Copyright 1999-2003 Diabetes In Control

For Questions about this website click here